CLYM

Climb Bio, Inc. Common Stock
CLYM

Overview Fund Activity

47 hedge funds and large institutions have $355M invested in Climb Bio, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
47
Holders Change
+26
Holders Change %
+123.81%
% of All Funds
0.68%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
31
Increased
10
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
RCM
1
RA Capital Management
Massachusetts
$223M
2
DTC
2
Deep Track Capital
Connecticut
$27.8M
3
SB
3
Samsara BioCapital
California
$23.2M
4
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$23.1M
5
BC
5
Boxer Capital
California
$18.5M

Top Sellers

1
BCM
1
BML Capital Management
Indiana
$0
2
DCM
2
Driehaus Capital Management
Illinois
$4.95M
3
AI
3
Atom Investors
Texas
$0
4
Tudor Investment Corp
4
Tudor Investment Corp
Connecticut
$0
5
Millennium Management
5
Millennium Management
New York
$81K
Name Holding Trade Value Shares
Change 		Shares
Change %
CPIG
51
Chicago Partners Investment Group
Illinois
– -$45.4K -12,104 Closed
Qube Research & Technologies (QRT)
52
Qube Research & Technologies (QRT)
United Kingdom
– -$2.69K -981 Closed
1 2
3